Global Investor | Strategic Advisor
Founded by Dr. Sascha Berger, BergerInvest partners with emerging and growth-stage companies as a strategic advisor and early investor, bridging science, capital, and execution across Europe, North America, and the Gulf.I operate as an investor, advisor, and bridge between global venture ecosystems and the Gulf.⸻💡 AdvisoryStrategic Advisory at Key Inflection PointsI work directly with founders and boards at moments that define outcomes: financing, strategy shifts, and international expansion.How I add value:
• Structuring and closing complex financing rounds
• Positioning companies for US, European, and Gulf market entry
• Board-level sparring on strategy, positioning, and execution⸻🌍 Ecosystem / Gulf StrategyConnecting Global Opportunity with Global CapitalBased in the Gulf, I work with sovereign wealth funds, family offices, and institutional investors on building and deploying capital into healthcare and deep tech.This includes direct exposure to the PIF ecosystem and the region’s rapidly evolving biotech and healthcare landscape.Activities include:
• Fund formation, mandate design, and portfolio construction
• Direct deal evaluation and co-investment structuring
• Closed-door briefings for investors entering the region
• Building cross-border partnerships across Europe, North America, and the Gulf⸻💶 InvestmentsSelective Investing & Co-InvestmentsI selectively invest my own capital and alongside trusted partners into high-conviction opportunities.Focus:
• Platform biotech with clear value inflection points
• Medtech with strong clinical and commercial leverage
• AI-driven healthcare models with defensible data or workflow advantages
• LP stakes and co-investments with leading VC and sovereign partners⸻👤 AboutDr. Sascha Berger is an investment executive, board member, and strategic advisor with two decades of experience at the intersection of science, finance, and innovation.Most recently, he built and led the biotech and AI investment platform at NEOM, part of Saudi Arabia’s Public Investment Fund ecosystem, helping shape one of the most ambitious life science initiatives globally.Previously, he served as General Partner at TVM Capital Life Science, where he led more than $100 million in biotech, medtech, and health AI investments across the US and Europe, including multiple successful exits and a NASDAQ IPO. He has partnered with leading global pharma and diagnostic companies such as Eli Lilly and Qiagen.Dr. Berger began his career at Deutsche Bank, BCG, PwC, and working with a leading German family office, building a foundation in strategy, M&A, and asset management. He has supported the structuring of cross-border investment platforms exceeding $500 million, served on multiple boards, and advised founders and investors on scaling breakthrough technologies.
He holds a PhD in Finance and a master in technology management (with biochemistry focus), with academic experience at the Technical University of Munich, the National University of Singapore, and MIT.Today, through BergerInvest, he operates as an investor and advisor, working with companies, funds, and institutional investors across Europe, North America, and the Gulf. His work focuses on high-impact technologies in biotech, medtech, healthtech and AI, as well as growth-stage healthcare services. Thus he is connecting capital with opportunity across regions.He serves on the Executive Board of the Life Science Acceleration Alliance (LSAA) and is a regular contributor to global industry forums including BIO International, JPM Healthcare, Jefferies Healthcare, and many others.Based in the Gulf and globally active, he continues to build bridges between capital, science, and execution.⸻✉️ ContactLet’s explore working together.Connect via email or LinkedIn